A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Reports Achieving Drug Safety Standards for Clinical Trials of its Drug for Treating Concussion
June 29, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, June 29, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International to Present at LD Micro Virtual Investor Conference 
June 08, 2021 07:00 ET | Odyssey Group International
IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
June 02, 2021 07:30 ET | Odyssey Group International
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
May 26, 2021 07:29 ET | Odyssey Group International
IRVINE, CA, May 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
May 24, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Completion of Novel Device for Nasal Delivery of Concussion Drug Candidate
May 19, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors
May 13, 2021 08:05 ET | Odyssey Group International
IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Welcomes Dr Bob Arnot to Scientific Advisory Board
May 11, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Formation of Scientific Advisory Board
April 14, 2021 07:59 ET | Odyssey Group International
Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
March 30, 2021 07:29 ET | Odyssey Group International
Irvine, CA, March 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing...